Ghrelin (OXE--103) for Acute Concussion Management
Clinical trial NCT04558346 · COMPLETED
Trial details
- NCT number
- NCT04558346
- Sponsor
- Michael Rippee
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-20
- Primary completion
- 2022-10-30
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.